Mutation screening of SCN2A in schizophrenia and identification of a novel loss-of-function mutation

Psychiatric Genetics

Volumn 26, Issue 2, 2016, Pages 60-65

  Carroll, Liam S ^a   Woolf, Rebecca ^a   Ibrahim, Yousef ^a   Williams, Hywel J ^a   Dwyer, Sarah ^a   Walters, James ^a   Kirov, George ^a   O'Donovan, Michael C ^a   Owen, Michael J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Gene; Loss of function; Missense; Mutation; Nonsense; Schizophrenia

Indexed keywords

MESSENGER RNA; SODIUM CHANNEL NAV1.2; SCN2A PROTEIN, HUMAN;

ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; HETEROZYGOTE; HIGH RESOLUTION MELTING ANALYSIS; HOMOZYGOTE; HUMAN; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA TRANSCRIPTION; SCHIZOPHRENIA; STOP CODON; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION; GENETICS; UNITED KINGDOM;

DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION, MISSENSE; NAV1.2 VOLTAGE-GATED SODIUM CHANNEL; SCHIZOPHRENIA; UNITED KINGDOM;

EID: 84960113636     PISSN: 09558829     EISSN: 14735873     Source Type: Journal    
DOI: 10.1097/YPG.0000000000000110     Document Type: Article

References (54)

1. Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, et al. (2010). A map of human genome variation from population-scale sequencing. Nature 467:1061-1073.
2. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE, et al. (2012). An integrated map of genetic variation from 1, 092 human genomes. Nature 491:56-65.
3. Adzhubei I, Jordan DM, Sunyaev SR (2013). Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet 7:20.
4. Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, et al. (2013). De novo mutations in epileptic encephalopathies. Nature 501:217-221.
5. Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, Yu F, et al. (2010). Integrating common and rare genetic variation in diverse human populations. Nature 467:52-58.
6. Artimo P, Jonnalagedda M, Arnold K, Baratin D, Csardi G, de Castro E, et al. (2012). ExPASy: SIB bioinformatics resource portal. Nucleic Acids Res 40(web server issue):W597-W603.
7. Boutry-Kryza N, Labalme A, Ville D, de Bellescize J, Touraine R, Prieur F, et al. (2015). Molecular characterization of a cohort of 73 patients with infantile spasms syndrome. Eur J Med Genet 58:51-58.
8. Carroll LS, Williams HJ, Walters J, Kirov G, O'Donovan MC, Owen MJ (2011). Mutation screening of the 3q29 microdeletion syndrome candidate genes DLG1 and PAK2 in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 156 B: 844-849.
9. Carvill GL, Mefford HC (2013). Microdeletion syndromes. Curr Opin Genet Dev 23:232-239.
10. Classen CF, Riehmer V, Landwehr C, Kosfeld A, Heilmann S, Scholz C, et al. (2013). Dissecting the genotype in syndromic intellectual disability using whole exome sequencing in addition to genome-wide copy number analysis. Hum Genet 132:825-841.
11. Codina-Solà M, Rodríguez-Santiago B, Homs A, Santoyo J, Rigau M, Aznar-Laín G, et al. (2015). Integrated analysis of whole-exome sequencing and transcriptome profiling in males with autism spectrum disorders. Mol Autism 6:21.
12. Cooper GM, Coe BP, Girirajan S, Rosenfeld JA, Vu TH, Baker C, et al. (2011). A copy number variation morbidity map of developmental delay. Nat Genet 43:838-846.
13. De Ligt J, Boone PM, Pfundt R, Vissers LE, Richmond T, Geoghegan J, et al. (2013). Detection of clinically relevant copy number variants with wholeexome sequencing. Hum Mutat 34:1439-1448.
14. De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Cicek AE, et al. (2014). Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515:209-215.
15. Dwyer S, Carroll L, Mantripragada KK, Owen MJ, O'Donovan MC, Williams NM (2010). Mutation screening of the DTNBP1 exonic sequence in 669 schizophrenics and 710 controls using high-resolution melting analysis. Am J Med Genet B Neuropsychiatr Genet 153 B: 766-774.
16. Exome Aggregation Consortium (ExAC) (2014). Cambridge, MA. Available at: http://exac.broadinstitute.org. [Accessed July 1st 2015].
17. Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP) (2014). Seattle, WA. Available at: http://evs.gs.washington. edu/EVS/. [Accessed May 1st 2015].
18. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, et al. (2014). De novo mutations in schizophrenia implicate synaptic networks. Nature 506:179-184.
19. Garrido JJ, Fernandes F, Moussif A, Fache MP, Giraud P, Dargent B (2003). Dynamic compartmentalization of the voltage-gated sodium channels in axons. Biol Cell 95:437-445.
20. Gilissen C, Hehir-Kwa JY, Thung DT, van de Vorst M, van Bon BW, Willemsen MH, et al. (2014). Genome sequencing identifies major causes of severe intellectual disability. Nature 511:344-347.
21. Girirajan S, Johnson RL, Tassone F, Balciuniene J, Katiyar N, Fox K, et al. (2013). Global increases in both common and rare copy number load associated with autism. Hum Mol Genet 22:2870-2880.
22. Guilmatre A, Dubourg C, Mosca AL, Legallic S, Goldenberg A, Drouin-Garraud V, et al. (2009). Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 66:947-956.
23. Hamshere ML, Walters JT, Smith R, Richards AL, Green E, Grozeva D, et al. (2013). Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry 18:708-712.
24. Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, et al. (2012). De novo gene disruptions in children on the autistic spectrum. Neuron 74:285-299.
25. Kamiya K, Kaneda M, Sugawara T, Mazaki E, Okamura N, Montal M, et al. (2004). A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline. J Neurosci 24:2690-2698.
26. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. (2002). The human genome browser at UCSC. Genome Res 12:996-1006.
27. Kirov G, Grozeva D, Norton N, Ivanov D, Mantripragada KK, Holmans P, et al. (2009). Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet 18:1497-1503.
28. Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, Ruderfer D, et al. (2012). De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 17:142-153.
29. Koressaar T, Remm M (2007). Enhancements and modifications of primer design program Primer3. Bioinformatics 23:1289-1291.
30. Kumar P, Henikoff S, Ng PC (2009). Predicting the effects of coding nonsynonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073-1081.
31. Kwong AK, Ho AC, Fung CW, Wong VC (2015). Analysis of mutations in 7 genes associated with neuronal excitability and synaptic transmission in a cohort of children with non-syndromic infantile epileptic encephalopathy. PLoS One 10:e0126446.
32. Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, Perlis RH, et al. (2013). Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 45:984-994.
33. Li J, Cai T, Jiang Y, Chen H, He X, Chen C, et al. (2015). Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database. Mol Psychiatry [Epub ahead of print].
34. Liao Y, Deprez L, Maljevic S, Pitsch J, Claes L, Hristova D, et al. (2010). Molecular correlates of age-dependent seizures in an inherited neonatal-infantile epilepsy. Brain 133(Pt 5):1403-1414.
35. Lim ET, Raychaudhuri S, Sanders SJ, Stevens C, Sabo A, MacArthur DG, et al. (2013). Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron 77:235-242.
36. Martin HC, Kim GE, Pagnamenta AT, Murakami Y, Carvill GL, Meyer E, et al. (2014). Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis. Hum Mol Genet 23:3200-3211.
37. Meisler MH, O'Brien JE, Sharkey LM (2010). Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects. J Physiol 588(Pt 11):1841-1848.
38. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, et al. (2008). Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40:1053-1055.
39. Owen MJ (2012). Implications of genetic findings for understanding schizophrenia. Schizophr Bull 38:904-907.
40. Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, Boursnell C, et al. (2012). The Pfam protein families database. Nucleic Acids Res 40(database issue):D290-D301.
41. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, et al. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460:748-752.
42. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, et al. (2014). A polygenic burden of rare disruptive mutations in schizophrenia. Nature 511:421-427.
43. Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T, et al. (2012). Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 380:1674-1682.
44. Ripke S, O'Dushlaine C, Chambert K, Mora JL, Kähler AK, Akterin S, et al. (2013). Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 45:1150-1159.
45. Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT, Moreno-De-Luca D, et al. (2011). Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70:863-885.
46. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, et al. (2012). De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485:237-241.
47. Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511:421-427.
48. Sherry ST, Ward M, Sirotkin K (1999). dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Res 9:677-679.
49. Shi X, Yasumoto S, Kurahashi H, Nakagawa E, Fukasawa T, Uchiya S, et al. (2012). Clinical spectrum of SCN2A mutations. Brain Dev 34:541-545.
50. Strange A, Riley BP, Spencer C C A, Morris DW, Brinen M, O'Dushlaine CT, et al. (2012). Genome-wide association study implicates HLA-C 01:02 as a risk factor at the major histocompatibility complex locus in schizophrenia. Biol Psychiatry 72:620-628.
51. Tavassoli T, Kolevzon A, Wang AT, Curchack-Lichtin J, Halpern D, Schwartz L, et al. (2014). De novo SCN2A splice site mutation in a boy with Autism spectrum disorder. BMC Med Genet 15:35.
52. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, Gravel S, et al. (2012). Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 337:64-69.
53. Woolfe A, Mullikin JC, Elnitski L (2010). Genomic features defining exonic variants that modulate splicing. Genome Biol 11:R20.
54. Zaidi S, Choi M, Wakimoto H, Ma L, Jiang J, Overton JD, et al. (2013). De novo mutations in histone-modifying genes in congenital heart disease. Nature 498:220-223.